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ABSTRACT
In vitpo transcription was used to show that RNA polymerase III is
responsible for the initiation of transcription at a position 200bp upstream
from the s-globin major cap site. High levels of -200 transcription
interferes with the RNA polymerase II major cap site transcription. Using DNA
mediated transient expression, the ratio of -200 to +1 transcription can be
modulated by either the direction of replication or the presence of an
enhancing element in the vector. We suggest that this heterogeneous usage of
cap sites is not related to s-globin gene transcription in vivo, but is
instead the result of a combination of factors inherent to transient
expression experiments.
INTRODUCTION
Recently a number of alternative initiation sites for transcription
have been found in several viral and cellular genes (1-7). In one case, the
amylase la gene, initiation heterogeneity was shown to correlate with tissue
(4) and stage (8) specific expression of the gene. However, in most cases,
such a correlation has not been rigorously established. For example, the
majority of globin gene transcription initiates at the mRNA cap site in
erythroid tissue, but there have been reports that at least the a-, yand
f-globin genes have other initiation sites in erythroid and other tissues (9,
10). In the case of the s-globin gene, such sites have been mapped to four
regions, -10 to -200, -850, -1430 and -4450bp from the major cap site (11).
Most of these longer transcripts are capped and account for about 10-15% of
the total s-globin transcripts, both in an erythroleukaemic cell line and
human embryonic erythroblasts (10). Approximately 5% of the total s-globin
transcripts in erythropoietic tissues originate from the -200 cap site alone
(11). Preliminary evidence indicates that these longer transcripts follow the
induction by hemin of the total s-globin mRNA population in K562 cells
(G. Kollias, unpublished). When non erythropoietic cell lines are transfected
with recombinants containing the c-globin gene together with the SV40 enhancer
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and/or the SV40 origin of replication, initiation of transcription from the
-200 cap site occurs at relatively higher rates compared to the in vivo
situation (12). Moreover, the -200 and the major cap site show a different
response to the SV40 elements included in the expression vectors (12). The
function of these upstream derived mRNAs with respect to the mechanism of
e-globin gene regulation is still unknown.
Analogous to-in vitro experiments on the upstream derived
transcripts of the human f- (13) and the mouse p-major (14) globin genes, we
demonstrate in this paper that the s-globin -200 cap site RNA is also
transcribed in vitrg by RNA polymerase III, while the +1 cap site RNA is
transcribed by RNA polymerase II. We have studied the modulation of these two
different promoters in transient assays using vectors containing the SV40
enhancer and/or the SV40 origin of replication. The results show that the
direction of vector replication by itself can determine the usage of either
the -200 cap site, or the major cap site. The results also suggest that
transcriptional interference from the -200 cap site is a second mechanism that
influences the expression of the +1 (major) cap site. Together, these two
elements explain the heterogeneous response of the s-globin gene +1 cap
transcription to viral cis-acting controls.
EIAL AND MEODS
Transfection of cell cultures - RNA urenaration - Si mamuinE
K562 cells were grown in RPMI1640 medium supplemented with 10% fetal
calf serum. Log phase cells were seeded at a concentration of 105
cells/ml. Cells were induced for four days in fresh medium containing 0.03mM
hemin. HeLa cells were grown in a-MEM medium supplemented with 10% newborn
calf serum. Calcium phosphate mediated DNA transfections were performed as
described by Wigler al. (15). 48 hzs after transfection, cells were
harvested and total RNA was prepared by the method of Chirgwin et al. (16).
SI mapping analysis of the RNA (17, 18) was performed using radioactively
labelled DNA probes as indicated in the figures.
In vitro transcriDtion
Transcription extracts were prepared as described by Manley et al
(19). Transcription assays were performed in 50pl containing 2.5pg DNA,
0.5mM ATP, 0.6mM CTP, 0.6mM GTP, 0.06mM UTP, 0.15mM EDTA, lmM creatine
phosphate and 10Ci [a-32P]UTP (400 Gi/mmole). Reactions were incubated
for 1 hr at 30 0C, followed by incubation 10 min. at 300C with an equal
volume of proteinase K mix (400 pg/ml proteinase K, l10 g wheat germ tRNA, 25mM
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EDTA, 100mM Tris-HCl pH. 7.5 and 2% SDS). The reaction mixture was then
extracted with phenol-chloroform, ethanol precipitated, washed with 70%
ethanol and dissolved in 7M Urea, 5mM Tris-borate 8.3, 1mM EDTA, 0.1%
bromophenol blue and 0.1% xylene cyanol. After heating at 1000C for 90
sec. RNA products were separated on a 5% polyacrylamide/urea gel (26).
BZ5ULTS
RNA Polvmerase III initiates transcri&tion at the -,200 ca site of
the a-elobin gene
It is well known that eucaryotic cell-free extracts can direct
transcription initiation events in various polymerase II or III DNA templates
(20, 21). In order to determine which RNA polymerase is responsible for the
transcription of the upstream derived a-globin RNA molecules, we used Jan
yitro transcription run-off assays with HeLa whole-cell extracts in the
presence of a-amanitin. RNA was transcribed from two different DNA templates
which contained either both the -200 and major cap site or only the latter.
The size of the RNA's was then analyzed on 5% acrylamide-urea gels (Fig. 2).
When RNA was transcribed from a 650bp BamHI fragment (Fig. 1), which
does not contain the -200 cap site, a band of approximately 475bp was observed
as expected (Fig. 2c, lane 1). This band represents the RNA transcript which
initiates at the major cap site of the c-globin gene. Synthesis of this RNA
species is inhibited by 2pg/ml a-amanitin indicating that it is transcribed by
RNA polymerase II (Fig. 2G, lane 2). The bands of approximately 650bp in the
same figure represent whole fragment transcripts always found in the in vitro
assays.
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Figi1: Restriction map of the s-globin gene and its flanking sequences.
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Fie. 2: Electrophoretic analysis of RNA synthesized on c-globin
templates. In vitro transcription assays were performed as described in
Materials and Methods and the products were analyzed on a 5%
polyacrylamide-urea gel.
(A): Transcription extracts were incubated with the 2.1kb BglII
fragment of s-globin gene (see Fig. 1A) containing both the -200 and the
major cap site (lane 1) RNA synthesized without a-amani&jn; (lane 2) 2pg/ml
cr-amanitin; (lane 3) lOOpg/ml a-amanitin. (lane M) [y- P]-ATP
labelled pBR322 x Hinf I DNA fragments. Autoradiography was for 15hrs at
-7000 with intensifying screen.
(B): As (A) but exposed for 5 days.
(C): Transcription extracts were incubated with the 0.6kb BamHI
fragment of s-globin gene (see Fig. lA) containing the major cap site but
not the -200 cap site (lane 1). RNA synthesized in the presence of no
additives. kane 2) 2pg/ml a-amanitin. (lane 3) 100pg/ml a-amanitin.
(lane M) [y- P]-ATP labelled pBR322 x HinfI DNA fragments.
Autoradiography was for 15hrs at -70 ° with intensifying screen.
Positions of RNA molecules with sizes corresponding to
transcription initiation from the -200 cap site or the major cap site are
indicated.
When RNA was transcribed from a 3190bp BglII fragment of the s-globin
gene (Fig. 1), the transcription pattern is quite different. This fragment
contains both the -200 cap site and the major cap site, together with 1.6kb of
5' flanking sequences. A prominent band of approximately 800bp was detected
which represents the RNA transcript originating from the -200 cap site (Fig.
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2A, lane 1). Synthesis of this RNA is not blocked by 2pg/ml a-amanitin (Fig.
2A, lane 2), but is inhibited by 100 pg/ml a-amanitin (Fig. 2A, lane 3)
indicating that it is transcribed by an a-amanitin insensitive RNA polymerase.
In a longer exposure of the same gel a very faint band of approximately 600bp
(Fig. 2B, lane 1) corresponding to the +1 cap site is visible. As expected,
this band is sensitive to 2pg/ml a-amanitin (lane 2). Other minor bands of no
obvious significance are also visible even after treatment with lOOpg/ml
a-amanitin.
It is interesting to note that active transcription from the -200 cap
site lowers the efficiency of transcription from the major cap site (Fig 2B
versus Fig. 2C) which suggests that a mechanism of transcriptional
interference might also act in vivo (see below) to regulate the quantitative
representation of the two different RNA populations in the total s-globin RNA.
Correct processing of the -200 cap site derived e-globin
To demonstrate that the s-globin RNA transcripts originating from the
-200 cap site undergo correct processing, we carried out an SI blot experiment
(Fig. 3) and confirmed the results by S1 mapping analysis (data not shown).
Total RNA was isolated from uninduced and induced K562 cells and from HeLa
cells transiently transformed with an s-pBSV construct (see below). In the
pBSV vector both the SV40 enhancer and the SV40 origin of replication are
present. This RNA was hybridized with the 3.7kb EcoRI fragment containing the
complete s-globin gene and upstream region. The DNA-RNA was digested with S1
endonuclease and electrophoresed on a 1.5% alkaline agarose gel. The DNA
bands were transferred to a nitrocellulose filter and hybridized to a
32P-nick translated 3.7kb EcoRI fragment. In the case of K562 RNA (Fig.
3, lanes 2, 3), a single band of 147 and a double band of 221 and 248
nucleotides were observed, corresponding to the exact size of the three exons
of the s-globin gene. However, in the case of the transiently expressed
s-globin RNA from the HeLa cell experiment, an additional prominent band of
360 nucleotides was observed. This corresponds to the distance from the -200
cap site to the first exon/intron junction, indicating c-globin RNA molecules
which are transcribed from the -200 cap site undergo correct processing at the
same splice junctions as the +1 cap site s-globin mRNA. Moreover, the -200
cap site transcript is polyadenylated and shows the same levels of
inducibility by hemin (2-3 fold) as the major cap site in K562 cells (data not
shown). Comparison of the relative activities between the -200 and the major
cap site in Fig. 3, lane 1, suggests that transcription interference of the
-200 cap site transcription with the major cap site transcription also plays a
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Fig. 3: Si blot analysis of s-globin mRNA species using the 3.7kb EcoRI
fragment of c-globin gene:
Si hybridizations were performed as described in Materials and
Methods using (1) total RNA from HeLa cells transfected with the 3.7spBSV
(5'->3') vector; (2) total uninduced K562 RNA and (3) total induced K562
RNA and the 3.7kb EcoRI fragment of s-globin gene. The Sl products were
electrophoresed on a 2% alkaline agarose gel (Favoloro et al, 1980),
eansferred to nitrocellulose filters and hybridized with a
P;Zaick-translated 3.7kb EcoRI fragment of s-globin gene. (lane M)
Y-4 P]-ATP labelled pBR322 x HindfII DNA fragments. Autoradiography
was for 5 hours at -70 0C with intensifying screen.
role in the HeLa cells, since the total sum of the relative densities of the
three exon bands is equal in the HeLa and K562 cells.
Effect of vector renlication on the transcrintion of a-elobin gene in HeLa
cells .
The 3. 7kb EcoRI fragment containing the e-globin gene was cloned into
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the SV40 vectors pBSV (22) pSVOD (23) and pSV2 (24). pBSV contains the 3.3kb
EcoRI-BamHI fragment of pBR328 linked to the 4.7kb EcoRI-BamHI fragment of
SV40. Thus, this vector contains the SV40 enhancer and origin of replication
sequences and can synthesize large T antigen required for replication. pSVOD
contains the 311bp EcoRII fragment of SV40 inserted into the EcoRI site of
essentially pBR327 with a deletion between HindIII site in pBR327 and the
HindIII site in SV40. This vector, therefore, contains the SV40 origin of
replication, but lacks the SV40 enhancer sequences. pSV2 contains only the
SV40 enhancer and the SV40 promoter sequences linked to the chloramphenicol
acetyl transferase (CAT) gene, together with pBR327. The SV40 origin of
replication is not included in this plasmid. To be able to use the same
constructs for transient expression experiments in s-globin expressing (K562)
and non expressing cells (HeLa), HindIII linkers (20bp) were ligated into the
PvuII site of the s-globin gene first exon. This small insertion does not
affect the transcriptional activity of the gene (data not shown). The 3.7kb
EcoRI fragment containing the (HindIII+) s-globin gene was ligated into the
EcoRI site of pBSV and pSVOD and into the 2.8kb EcoRI fragment of pSV2.
Recombinants containing both possible orientations of the c-globin gene
relative to SV40 sequences were isolated (Fig. 4B). In all cases, 5'->3'
orientation indicates that direction of SV40 early transcription is in the
same orientation as the c-globin gene transcription; 3'->5' orientation
indicates the opposite.
To study the effect of the SV40 enhancer and/or the SV40 origin of
replication on the overall transcription of the s-globin gene, we introduced
all of the c-globin recombinants into HeLa cells by calcium phosphate
coprecipitation (15). Total RNA was prepared 48 hrs after transfection and 5'
s-globin RNA termini were located by Si mapping using the 391bp (HindIII+)
MboII fragment spanning both the -200 and the major cap site (Fig. 4A).
As shown in Fig. 4A, lanes, 3, 4 and 9, when both the SV40
enhancement and replication were absent. no expression of e-globin gene could
be detected even after long exposures (not shown). In all other cases where
both or either of the two SV40 elements under study are present, both -200 and
+1 cap transcripts are visible. It should be noted that the object of this
experiment is to compare the qualitative differences between the -200 and +1
cap-transcripts (i.e. compare within a lane). We did not include an internal
marker plasmid to avoid any unwanted trans-acting effects on the s-globin
plasmid. Consequently, quantitative comparisons between lanes are not
accurate, since we have observed as much as a two-fold difference in
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transformation efficiencies between experiments. The presence of the SV40
enhancer in the vector (lanes 7 and 8) gives an increase in the number of
transcripts originating from both the -200 and +1 cap sites. The difference
between the -200 signal from the two gene orientations (lanes 7 and 8) is not
consistent when several experiments are compared with each other. However, an
orientation effect is very reproducible when the vector is replicated by the
addition of an SV40 origin (lanes 5 and 6). The pattern of transcription from
the two cap sites seems to be inverted with respect to the orientation of the
replication fork. Activation of the -200 cap site is highest when the
transcribed strand of the s-globin gene corresponds tothe discontinuously
synthesized strand. In the opposite orientation, the major cap site is
A rep++
enh + +
M 1 2 3
517- 0I-reru7DUO
396-
344-
298- .
+-
+§
4 56 78910M
a
vftWM _-- soam_-tf
_ ,_ A4. ,
220- 0
154- a
-
44*
- OQ-
=
-0
391
151 I
366
8000
Nucleic Acids Research
E
m3.7 \
Hil cap pBR327
X B ^ s iHlil,XPst~~~~Hil
E
E E
Pi.EAEf et4of ci-cigS4 lmnsntetasrpino
(2)m3.7 Hil ap m3.7c Hill ap -m37Hill ap pB5V H PSVODp ()SV2
E E
E E
Hill m3.73( ' Hillm3.7l m3. l I
(3-5)and3Hilth Pst I
E E
Fig. 4A: Effect of cis-acting SV40 elements on the transcription of
se-globin gene in short term transformants.
HeLa cells were transfected with10ng of (I) m3.7spBSV(5v->3t)o
(2) m3.7tRpBSV (32->5'),(3) m3.7epSVOD (52->3'),(4) m3.7apSVOD (32->5.),
(5) m3.7cpSVOD (5o->3t) + lOpg pBSV, (6) m3.7cpSVOD(3a->5) + nling pBSV,
(7) m3.VspSV2(5ea>3r)T (8) m3.7apSV2 (3o->5') and (9)m3.7tpBR327. In all
cases except (5) and (6) the cells were cotransfected with lOpg of salmon
sperm DNA. Total RNA was prepared 48 hrs later and s-globin RNA 5' termini
were mapped by SI nuclease using a 5' labelled MboII-MboII probe. Total
HeLa cell RNA (lane 10) was used as a negative control.*Lane M contains
pBR322 x HinfI fragments. Autoradiography was for 45 hrs at -7000 with
intensifying screen. The presence of the SV4o enhancer and the function of
the SV40 origin of replication on the transfection vectors is indicated on
the upper part of the figure. Expected sizes for the -200 or the major cap
site protection of the probe is shown at the bottom of the figure.
Pi. B Construction of transfection vectors:
The 3.7kb EcoRI fragment of the human e-globin gene was inserted
into the EcoRI site of vectors (pBSV (22). pSVOD (23) and pSV2 (24).
pBSV contains both the SV40 origin of replication and the SV40 enhancer,
pSVOD contains only the SV40 origin of replication and pSV2 contains only
the SV40 enhancer. The orientation of e-globin transcription and SV40
early transcription is indicated.
activated. This result, therefore, supports the model by Smithies (25) which
proposes differential activity of replication as a mechanism to control gene
activation. Interestingly, when replication takes place in the presence of an
enhancer (lanes I and 2), the stimulatory effect on the -200 cap site
8001
Nucleic Acids Research
transcription appears to be "additive' and leads to such an effective -200 cap
transcription that it interferes with the downstream +1 cap transcription to
give a level lower than that found in the presence of only an enhancer.
DISCUSSION
In recent years information has accumulated concerning alternative
transcription initiation sites for the human u-related globin genes (9, 12).
The most studied case has been that of the human embryonic c-globin gene, in
which transcription from a site -200bp upstream from the major cap site
accounts for approximately 5% of the total c-globin gene expression in human
embryos and in cultured cell lines (10). Quite surprisingly, the -200 cap
site (11) is used for unknown reasons to a greater extent (up to 80% of the
total s-globin transcripts) in short term transformed cell lines (12) and
under the control of cis-acting SV40 elements.
It has recently been reported (13, 14) that the 3-globin
upstreamr-derived RNAs are transcribed in vitro by RNA pol III and that the
sequences flanking the proposed initiation sites closely resemble classical
pol III promoters. No information was available as to which polymerase
transcribes the upstream derived s-globin species. We show that an a-amanitin
insensitive polymerase produces RNAs of the same size as those that originate
from a site -200bp upstream from the major c-globin cap site in vivo (Fig. 2).
Although RNA pol III would be the best candidate for such properties, a
comparison of the c-globin sequences around the alternative initiation site
with pol III promoter consensus sequences (27) failed to reveal a strong
homology. The longer transcripts behave similarly to the major cap site
derived ones with regard to splicing (Fig. 3) and inducibility by hemin (not
shown). At this stage we can only speculate on the role of these RNA
molecules in vivo, either in general cellular mechanisms or more specifically
in the regulation of globin gene expression. There is a possibility that
these longer pol III transcripts could play a trans-acting regulatory role,
either as an RNA molecule, or by the production of a polypeptide. There are
indeed two possible AUG codons between the two alternative cap sites,
translation from which could give rise to polypeptides with 41 and 38 amino
acids. Alternatively, the upstream transcript could have a cis regulatory
role on the transcription of the s-globin gene. For example, the results in
Fig. 2 suggest that interference could take place by the -200 cap on the +1
cap transcription. However, since a high level of -200 cap transcripts or a
changing ratio of -200 to +1 cap transcripts is not observed in human tissues
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(10), in vivo interference appears unlikely.
When plasmids containing the c-globin gene, but lacking both viral
elements, are introduced into HeLa cells (3.7epBR327 - Fig. 4A, lane 9)
transcription from either the -200 cap site or the major cap site is
undetectable (even after long exposure times). The same result is obtained
when HeLa cells are transfected with the 3.7epSVOD construct alone (Fig. 4A,
lanes 3, 4). In the latter case there is no T-antigen for the replication
from the SV40 origin and the vector remains inactive. At present we do not
know why this result is different from previous observations which showed a
50-fold greater transcription initiation from the -200 cap site over that from
the major cap site (12), although it should be pointed out that a different
cell line was used.
In all other cases when plasmids containing the c-globin gene,
together with the SV40 enhancer and/or the origin of replication were used,
initiation of transcription occurred at both the -200 cap site and the major
cap site. It has been shown that the SV40 enhancer increases RNA pol II
density within the linked gene (28, 29) which would explain the high level of
transcription from the c-globin major cap site in relation to the -200 cap
site in the 3.7apSV2 vector (enhancer only, Fig. 4A, lanes 7, 8). The
increased density of RNA pol II molecules at the major cap site promoter may
not allow efficient transcription of the RNA pol III transcribed -200 cap
site.
The most interesting result was obtained when we used the s-globin
pSVOD consruct cotransfected with the pBSV vector. The result clearly shows
that in the orientation in which the direction of transcription of the
c-globin gene is colinear with the continuously synthesized strand of
replication, initiation of transcription from the major cap site is much more
active than from the -200 cap site (Fig. 4A, lane 6). The pattern closely
resembles the in vivo situation in erythropoietic cells. In the opposite
orientation of the replication fork (Fig. 4A, lane 5), the -200 cap site seems
to be stimulated while the major site shows very little activity (which could
be due to the transcriptional interference from the active -200 cap site). It
seems, therefore, that the asymmetry of the replication event is reflected in
an asymmetrical pattern of s-globin gene transcription in relation to the -200
and the major cap site. Limited support for replication influencing upstream
transcription has been obtained by studies in adenovirus (30) and SV40 (31).
In summary, data presented here and previous transient expression
experiments (12) demonstrate heterogeneous regulation of the c-globin gene
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-200 and major cap site transcription in relation to the SV40 elements used.
We would suggest that extreme care should be taken with the interpretation of
transient expression experiments when multiple factors are changed by the
introduction of an enhancer or an origin of replication. In contrast to the
previous report (12) we would consider it most likely that the heterogeneous
-200 cap/+1 cap expression is the result of in vitro manipulation (vectors,
cell lines etc.) in transient expression experiments. The wider significance
of our data for the normal regulation of the human s-globin gene transcription
in the yolk sac i , are implied from the demonstration that
transcriptional interference (negative) or the direction of replication could
play a regulatory role.
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